Toth Financial Advisory Corp decreased its stake in Aflac Incorporated (NYSE:AFL – Free Report) by 0.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 75,386 shares of the financial services provider’s stock after selling 113 shares during the quarter. Toth Financial Advisory Corp’s holdings in Aflac were worth $7,798,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of the stock. International Assets Investment Management LLC boosted its holdings in Aflac by 10,878.5% in the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock worth $62,597,000 after buying an additional 554,803 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Aflac by 471.4% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider’s stock valued at $67,080,000 after acquiring an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Aflac by 670.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock worth $57,572,000 after acquiring an additional 484,378 shares during the last quarter. Truist Financial Corp increased its position in shares of Aflac by 26.6% during the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock worth $172,338,000 after purchasing an additional 405,847 shares in the last quarter. Finally, World Investment Advisors LLC acquired a new position in Aflac in the 3rd quarter valued at $42,290,000. Institutional investors and hedge funds own 67.44% of the company’s stock.
Insider Activity at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.90% of the company’s stock.
Aflac Trading Up 0.3 %
Aflac (NYSE:AFL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm’s quarterly revenue was down 40.4% on a year-over-year basis. During the same quarter last year, the company posted $1.84 EPS. On average, sell-side analysts anticipate that Aflac Incorporated will post 7.26 earnings per share for the current year.
Aflac Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be paid a $0.58 dividend. The ex-dividend date is Wednesday, February 19th. This is a boost from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.21%. Aflac’s payout ratio is presently 30.12%.
Analysts Set New Price Targets
Several brokerages have issued reports on AFL. StockNews.com raised shares of Aflac from a “sell” rating to a “hold” rating in a research note on Wednesday, January 8th. TD Cowen assumed coverage on shares of Aflac in a research note on Wednesday, October 9th. They issued a “hold” rating and a $102.00 target price on the stock. JPMorgan Chase & Co. upped their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research report on Tuesday, January 7th. Evercore ISI reduced their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research report on Wednesday, December 4th. Finally, Keefe, Bruyette & Woods dropped their target price on Aflac from $108.00 to $107.00 and set a “market perform” rating for the company in a report on Friday, January 10th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus price target of $102.67.
Get Our Latest Analysis on Aflac
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories
- Five stocks we like better than Aflac
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Bloom Energy: Powering the Future With Decentralized Energy
- What Are the FAANG Stocks and Are They Good Investments?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- Business Services Stocks Investing
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.